Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

This publication has 23 references indexed in Scilit:

• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets
  Biochemical and Biophysical Research Communications, 1976
• Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid
  Inflammation Research, 1975
• Stimulation of human platelet adenylate cyclase by prostaglandin D2
  Thrombosis Research, 1974
• THE CONTROL OF PLATELET RESPONSIVENESS BY AGENTS THAT INFLUENCE CYCLIC AMP METABOLISM
  Annals of the New York Academy of Sciences, 1972
• Platelet aggregation IV. Platelet phosphodiesterase and its inhibition by vasodilators
  Biochemical and Biophysical Research Communications, 1971
• The interaction of norepinephrine and prostaglandin E1 on the adenyl cyclase system of human and rabbit blood platelets
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1971
• Cyclic 3′,5′-Adenosine Monophosphate in Human Blood Platelets
  Nature, 1969
• β-Adrenergic receptors in human platelets
  Journal of Atherosclerosis Research, 1969